These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 6398782

  • 1. Effects of oxygen therapy on pulmonary arterial hypertension in chronic obstructive lung disease.
    Zielinski J.
    G Ital Cardiol; 1984; 14 Suppl 1():61-3. PubMed ID: 6398782
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Acute and long-term effects of chronic obstructive lung diseases].
    Klein G, Matthys H.
    Pneumologie; 1990 Feb; 44 Suppl 1():188-90. PubMed ID: 2114622
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evolution of pulmonary hypertension in chronic obstructive pulmonary diseases.
    Weitzenblum E, Mammosser M, Ehrhart M.
    G Ital Cardiol; 1984 Feb; 14 Suppl 1():33-8. PubMed ID: 6534764
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
    Adnot S, Samoyeau R, Weitzenblum E.
    Blood Press Suppl; 1995 Feb; 3():47-57. PubMed ID: 8535542
    [Abstract] [Full Text] [Related]

  • 9. Low-dose inhalation therapy with nitric oxide and oxygen--implications for long-term application in patients with COPD and pulmonary hypertension.
    Leitner C, Ziesche R, Zimpfer M, Block LH, Germann P.
    Acta Anaesthesiol Scand Suppl; 1996 Feb; 109():96-7. PubMed ID: 8901962
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Low dose inhalation of nitric oxide in chronic obstructive pulmonary diseases].
    Yoshida M, Taguchi O, Gabazza EC, Yasui H, Kobayashi T, Yamakami T, Kobayashi H.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jan; 35(1):56-60. PubMed ID: 9071157
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Two-week nifedipine treatment for pulmonary hypertension complicating chronic obstructive lung disease.
    Saadjian A, Philip-Joet F, Guintoli A, Torresani J, Arnaud A.
    Eur J Respir Dis; 1985 Nov; 67(5):346-50. PubMed ID: 4085586
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation problems of a long-term study on evolving pulmonary arterial hypertension in chronic non specific lung disease.
    Naszlady A, Rodek I.
    G Ital Cardiol; 1984 Nov; 14 Suppl 1():49-55. PubMed ID: 6534767
    [Abstract] [Full Text] [Related]

  • 17. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
    Weitzenblum E, Chaouat A, Canuet M, Kessler R.
    Semin Respir Crit Care Med; 2009 Aug; 30(4):458-70. PubMed ID: 19634085
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Modification of pulmonary hypertension in patients with chronic obstructive lung diseases using calcium antagonists in an acute trial].
    Schauer J, Himmel W, Orschekowski H.
    Z Gesamte Inn Med; 1989 Jan 15; 44(2):50-4. PubMed ID: 2650472
    [Abstract] [Full Text] [Related]

  • 20. [Pulmonary arterial pressure in chronic bronchitis with respiratory insufficiency on long-term oxygen therapy. Outcome of 16 patients with review of the literature].
    Geraads A, Pirotte C, Ligeonnet D, Levy P, Brambilla C.
    Rev Mal Respir; 1984 Jan 15; 1(2):119-24. PubMed ID: 6463353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.